Masitinib in Combination With Gemcitabine for Treatment of Patients With Advanced/Metastatic Pancreatic Cancer
Status:
Completed
Trial end date:
2012-08-31
Target enrollment:
Participant gender:
Summary
The objective of this study is to compare the efficacy and safety of masitinib in combination
with gemcitabine to placebo in combination with gemcitabine in patients with
advanced/metastatic pancreatic cancer.